BioMark Diagnostics Inc. (BUX.CN)
CAD 0.2
(0.0%)
CAD 0.2
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -982.52 Thousand | -914.42 Thousand | -1.2 Million | -455.55 Thousand | -453.78 Thousand | -277.83 Thousand |
| Net Income | -1.42 Million | -1.84 Million | -1.45 Million | -1.09 Million | -1.21 Million | -545.61 Thousand |
| Depreciation & Amortization | 393.17 Thousand | 386.19 Thousand | 179.62 Thousand | 13.68 Thousand | 11.9 Thousand | - |
| Deferred income taxes | - | - | - | -13.56 Thousand | 15 Thousand | - |
| Stock-based compensation | 75.48 Thousand | 329.52 Thousand | - | 395.48 Thousand | 855.89 Thousand | 2028.00 |
| Change in working capital | -86.45 Thousand | 137.62 Thousand | 42.61 Thousand | 240.48 Thousand | -127.3 Thousand | 265.74 Thousand |
| Other non-cash items | 933.13 Thousand | 74.46 Thousand | 27.74 Thousand | 2556.00 | 5999.00 | 1329.00 |
| Investing Cash Flow | -4394.00 | -5299.00 | -59.2 Thousand | -3200.00 | -790.00 | - |
| Investments in PPE | -4394.00 | -5299.00 | -59.2 Thousand | - | -790.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -3200.00 | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -3200.00 | - | - |
| Financing Cash Flow | 1.07 Million | 609.04 Thousand | 768.16 Thousand | 724.62 Thousand | 1.04 Million | 261.2 Thousand |
| Debt repayment | -732.64 Thousand | -384.98 Thousand | -310.78 Thousand | -11.98 Thousand | -10.18 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.89 Million | 961.32 Thousand | 662.3 Thousand | 1.05 Million | 709.12 Thousand | 222.1 Thousand |
| Other Financing Activities | -412.95 Thousand | 32.71 Thousand | 416.63 Thousand | -322.12 Thousand | 347.45 Thousand | 39.1 Thousand |
| Accounts receivables | -8654.00 | 47.75 Thousand | -54.96 Thousand | -11.04 Thousand | -3546.00 | 699.00 |
| Accounts payables | - | - | - | -82.05 Thousand | -52.07 Thousand | 3463.00 |
| Inventory | - | - | - | - | - | - |
| Other working capital | -77.79 Thousand | 89.87 Thousand | 97.57 Thousand | 333.58 Thousand | -71.67 Thousand | 261.58 Thousand |
| Cash at beginning of period | 72.03 Thousand | 382.71 Thousand | 877.67 Thousand | 611.8 Thousand | 19.99 Thousand | 36.63 Thousand |
| Cash at end of period | 156.74 Thousand | 72.03 Thousand | 382.71 Thousand | 877.67 Thousand | 611.8 Thousand | 19.99 Thousand |
| Capital Expenditure | -4394.00 | -5299.00 | -59.2 Thousand | - | -790.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 84.71 Thousand | -310.67 Thousand | -494.96 Thousand | 265.87 Thousand | 591.8 Thousand | -16.63 Thousand |
| Free Cash Flow | -986.91 Thousand | -919.72 Thousand | -1.26 Million | -455.55 Thousand | -454.57 Thousand | -277.83 Thousand |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -623.27 Thousand | -391.3 Thousand | -1.42 Million | -406.76 Thousand | -210.46 Thousand | -418.85 Thousand |
| Depreciation & Amortization | 57.75 Thousand | 100.84 Thousand | 393.17 Thousand | 99.3 Thousand | 90.51 Thousand | 102.77 Thousand |
| Deferred income taxes | - | - | - | -231.62 Thousand | - | - |
| Stock-based compensation | 209.38 Thousand | -8530.00 | 75.48 Thousand | 15.79 Thousand | 32.44 Thousand | 35.76 Thousand |
| Change in working capital | 16.53 Thousand | 67.02 Thousand | -86.45 Thousand | -230.67 Thousand | 62.09 Thousand | 15.1 Thousand |
| Other non-cash items | 18.9 Thousand | 206.24 Thousand | 933.13 Thousand | 247.52 Thousand | 13.55 Thousand | 15.43 Thousand |
| Investing Cash Flow | -2508.00 | -1236.00 | -4394.00 | -2201.00 | -957.00 | - |
| Investments in PPE | -2508.00 | -1236.00 | -4394.00 | -2201.00 | -957.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 307.81 Thousand | 59.41 Thousand | 1.07 Million | 653.21 Thousand | 6017.00 | 352.97 Thousand |
| Debt repayment | -102.87 Thousand | -295.13 Thousand | -732.64 Thousand | -101.08 Thousand | -234.76 Thousand | -101.66 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 373.88 Thousand | 350 Thousand | 1.89 Million | 983.06 Thousand | 166.97 Thousand | 391.83 Thousand |
| Other Financing Activities | 410.68 Thousand | -187.7 Thousand | -412.95 Thousand | -228.76 Thousand | 73.8 Thousand | 62.8 Thousand |
| Accounts receivables | 12.01 Thousand | 4429.00 | -8654.00 | -17.21 Thousand | -5778.00 | 9912.00 |
| Accounts payables | - | - | - | - | - | 5197.00 |
| Inventory | - | - | - | - | - | -5197.00 |
| Other working capital | 4526.00 | -75.77 Thousand | -77.79 Thousand | -213.45 Thousand | 67.87 Thousand | 5197.00 |
| Cash at beginning of period | 156.74 Thousand | 313.03 Thousand | 72.03 Thousand | 168.44 Thousand | 175.23 Thousand | 72.03 Thousand |
| Cash at end of period | 141.35 Thousand | 156.74 Thousand | 156.74 Thousand | 313.03 Thousand | 168.44 Thousand | 175.23 Thousand |
| Capital Expenditure | -2508.00 | -1236.00 | -4394.00 | -2201.00 | -957.00 | - |
| Effect of forex changes on cash | - | - | - | -1.00 | - | - |
| Net cash flow / Change in cash | -15.39 Thousand | -156.28 Thousand | 84.71 Thousand | 144.58 Thousand | -6792.00 | 103.2 Thousand |
| Free Cash Flow | -323.2 Thousand | -215.7 Thousand | -986.91 Thousand | -508.63 Thousand | -12.8 Thousand | -249.77 Thousand |
GR
BKSC
PGOL
JYOTHYLAB
TSUKY
TGKB